184 related articles for article (PubMed ID: 29530488)
1. Modified Lung-RADS Improves Performance of Screening LDCT in a Population with High Prevalence of Non-smoking-related Lung Cancer.
Hsu HT; Tang EK; Wu MT; Wu CC; Liang CH; Chen CS; Mar GY; Lai RS; Wang JC; Wu CL; Huang YL; Wu FZ
Acad Radiol; 2018 Oct; 25(10):1240-1251. PubMed ID: 29530488
[TBL] [Abstract][Full Text] [Related]
2. Cancer Risk in Subsolid Nodules in the National Lung Screening Trial.
Hammer MM; Palazzo LL; Kong CY; Hunsaker AR
Radiology; 2019 Nov; 293(2):441-448. PubMed ID: 31526256
[TBL] [Abstract][Full Text] [Related]
3. Application of Lung-Screening Reporting and Data System Versus Pan-Canadian Early Detection of Lung Cancer Nodule Risk Calculation in the Alberta Lung Cancer Screening Study.
Tremblay A; Taghizadeh N; MacGregor JH; Armstrong G; Bristow MS; Guo LLQ; Lydell C; Pereira R; Lee A; Elliot T; MacEachern P; Graham A; Dickinson JA; Koetzler R; Lam SC; Yang H; Bédard EL; Tammemagi M; Burrowes P
J Am Coll Radiol; 2019 Oct; 16(10):1425-1432. PubMed ID: 31103442
[TBL] [Abstract][Full Text] [Related]
4. Strategies for Reducing False-Positive Screening Results for Intermediate-Size Nodules Evaluated Using Lung-RADS: A Secondary Analysis of National Lung Screening Trial Data.
Hammer MM; Hunsaker AR
AJR Am J Roentgenol; 2022 Sep; 219(3):397-405. PubMed ID: 35319912
[No Abstract] [Full Text] [Related]
5. Evaluation of Lung Cancer Risk Among Persons Undergoing Screening or Guideline-Concordant Monitoring of Lung Nodules in the Mississippi Delta.
Osarogiagbon RU; Liao W; Faris NR; Fehnel C; Goss J; Shepherd CJ; Qureshi T; Matthews AT; Smeltzer MP; Pinsky PF
JAMA Netw Open; 2023 Feb; 6(2):e230787. PubMed ID: 36848089
[TBL] [Abstract][Full Text] [Related]
6. Artificial neural networks improve LDCT lung cancer screening: a comparative validation study.
Hsu YC; Tsai YH; Weng HH; Hsu LS; Tsai YH; Lin YC; Hung MS; Fang YH; Chen CW
BMC Cancer; 2020 Oct; 20(1):1023. PubMed ID: 33092589
[TBL] [Abstract][Full Text] [Related]
7. Comparison Between Radiological Semantic Features and Lung-RADS in Predicting Malignancy of Screen-Detected Lung Nodules in the National Lung Screening Trial.
Li Q; Balagurunathan Y; Liu Y; Qi J; Schabath MB; Ye Z; Gillies RJ
Clin Lung Cancer; 2018 Mar; 19(2):148-156.e3. PubMed ID: 29137847
[TBL] [Abstract][Full Text] [Related]
8. Ultra-low-dose CT reconstructed with ASiR-V using SmartmA for pulmonary nodule detection and Lung-RADS classifications compared with low-dose CT.
Ye K; Chen M; Li J; Zhu Q; Lu Y; Yuan H
Clin Radiol; 2021 Feb; 76(2):156.e1-156.e8. PubMed ID: 33293025
[TBL] [Abstract][Full Text] [Related]
9. External validation and comparison of the Brock model and Lung-RADS for the baseline lung cancer CT screening using data from the Korean Lung Cancer Screening Project.
Kim H; Kim HY; Goo JM; Kim Y
Eur Radiol; 2021 Jun; 31(6):4004-4015. PubMed ID: 33241512
[TBL] [Abstract][Full Text] [Related]
10. Cancer Risk in Nodules Detected at Follow-Up Lung Cancer Screening CT.
Hammer MM; Byrne SC
AJR Am J Roentgenol; 2022 Apr; 218(4):634-641. PubMed ID: 34755524
[No Abstract] [Full Text] [Related]
11. Assessment of Selection Criteria for Low-Dose Lung Screening CT Among Asian Ethnic Groups in Taiwan: From Mass Screening to Specific Risk-Based Screening for Non-Smoker Lung Cancer.
Wu FZ; Huang YL; Wu CC; Tang EK; Chen CS; Mar GY; Yen Y; Wu MT
Clin Lung Cancer; 2016 Sep; 17(5):e45-e56. PubMed ID: 27133540
[TBL] [Abstract][Full Text] [Related]
12. Real-World Lung Cancer CT Screening Performance, Smoking Behavior, and Adherence to Recommendations: Lung-RADS Category and Smoking Status Predict Adherence.
Barbosa EJM; Yang R; Hershman M
AJR Am J Roentgenol; 2021 Apr; 216(4):919-926. PubMed ID: 32755178
[No Abstract] [Full Text] [Related]
13. Malignancy estimation of Lung-RADS criteria for subsolid nodules on CT: accuracy of low and high risk spectrum when using NLST nodules.
Chung K; Jacobs C; Scholten ET; Mets OM; Dekker I; Prokop M; van Ginneken B; Schaefer-Prokop CM
Eur Radiol; 2017 Nov; 27(11):4672-4679. PubMed ID: 28439653
[TBL] [Abstract][Full Text] [Related]
14. Vancouver Risk Calculator Compared with ACR Lung-RADS in Predicting Malignancy: Analysis of the National Lung Screening Trial.
White CS; Dharaiya E; Dalal S; Chen R; Haramati LB
Radiology; 2019 Apr; 291(1):205-211. PubMed ID: 30667335
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval.
Silva M; Milanese G; Sestini S; Sabia F; Jacobs C; van Ginneken B; Prokop M; Schaefer-Prokop CM; Marchianò A; Sverzellati N; Pastorino U
Eur Radiol; 2021 Apr; 31(4):1956-1968. PubMed ID: 32997182
[TBL] [Abstract][Full Text] [Related]
16. Lung-RADS Version 1.1: Challenges and a Look Ahead, From the
Chelala L; Hossain R; Kazerooni EA; Christensen JD; Dyer DS; White CS
AJR Am J Roentgenol; 2021 Jun; 216(6):1411-1422. PubMed ID: 33470834
[TBL] [Abstract][Full Text] [Related]
17. A simple prediction model using size measures for discrimination of invasive adenocarcinomas among incidental pulmonary subsolid nodules considered for resection.
Kim H; Goo JM; Park CM
Eur Radiol; 2019 Apr; 29(4):1674-1683. PubMed ID: 30255253
[TBL] [Abstract][Full Text] [Related]
18. Performance of ACR Lung-RADS in a clinical CT lung screening program.
McKee BJ; Regis SM; McKee AB; Flacke S; Wald C
J Am Coll Radiol; 2015 Mar; 12(3):273-6. PubMed ID: 25176499
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Radiomic Models Based on Low-Dose and Standard-Dose CT for Prediction of Adenocarcinomas and Benign Lesions in Solid Pulmonary Nodules.
Liu J; Xu H; Qing H; Li Y; Yang X; He C; Ren J; Zhou P
Front Oncol; 2020; 10():634298. PubMed ID: 33604303
[TBL] [Abstract][Full Text] [Related]
20. Circulating Tumor-Macrophage Fusion Cells and Circulating Tumor Cells Complement Non-Small-Cell Lung Cancer Screening in Patients With Suspicious Lung-RADS 4 Nodules.
Manjunath Y; Suvilesh KN; Mitchem JB; Avella Patino DM; Kimchi ET; Staveley-O'Carroll KF; Pantel K; Yi H; Li G; Harris PK; Chaudhuri AA; Kaifi JT
JCO Precis Oncol; 2022 Mar; 6():e2100378. PubMed ID: 35417204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
